NERM
PODD icon

New England Research & Management’s Insulet PODD Stock Holding History

New England Research & Management’s Portfolio PODD Stock Details PODD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,500
Closed -$315K – 162
2026
Q1 		$315K Sell
1,500
-2,100
-58% -$528K 0.13% 126
2025
Q4 		$1.02M Buy
+3,600
New +$1.13M 0.45% 72

Other funds holding PODD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

New England Research & Management's PODD Position: Q2 2026 in Review

New England Research & Management sold out of Insulet (PODD) in Q2 2026, closing a stake of 1,500 shares — an estimated $315K sold.

New England Research & Management first reported a position in PODD in Q4 2025 and held it in 2 quarters. The position peaked at $1.02M in Q4 2025. 720 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • New England Research & Management reported no remaining Insulet position as of Q2 2026 after selling out during the quarter.
  • New England Research & Management sold 1,500 Insulet shares in Q2 2026, an estimated $315K.
  • New England Research & Management first reported a position in Insulet in Q4 2025 and held it in 2 quarters.
  • New England Research & Management's Insulet position peaked at $1.02M in Q4 2025.
  • 720 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on New England Research & Management's 13F filing for Q2 2026, filed 9 Jul 2026.